Skip to contentP
Prestige Consumer Healthcare Inc.
P
PBHPrestige Consumer Healthcare Inc. Q3 2021 · 10-Q
Revenue$238.79M$238.79M−1.1% vs Q3 2020 Net Income$40.87M$40.87M+7.4% vs Q3 2020 EPS Diluted$0.81$0.81+8.0% vs Q3 2020 Gross Profit$138,887,000+1.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
Operating Cash Flowderived$49,227,000−15.1% Free Cash Flowderived$43,499,000−20.6% Margins · derivedGross margin58.2%+1.2 pt vs Q3 2020
Operating margin30.8%−0.9 pt vs Q3 2020
Net margin17.1%+1.4 pt vs Q3 2020
ended Dec 31, 2020 · filed Feb 4, 2021 · 35 d after period end